Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
What's Inside
 
Subscribe

Subscribe with Atom
Subscribe with RSS 2.0
[What is this?]

Archives

View all

Recent Posts
This weblog is licensed under a Creative Commons License.

Powered by Movable Type.

Minnesota Gene Pool Blog

« Race: Are we so different? | Main | Norman Borlaug, Super Hero »

AHRQ Report on the use of CYP450 genetic tests in prescribing SSRI's in treating depression

The Agency for Healthcare Research and Quality (AHRQ) and the Centers for Disease Control and Prevention's (CDC) National Office of Public Health Genomics (NOPHG) have released a report examining the evidence for using Cytochrome P450 tests in prescribing selective serotonin reuptake inhibitors (SSRIs) for adults with depression.

The findings of this report are that there is insufficient information to support the use of this testing in clinical practice and that more well designed studies are needed to determine the clinical value for patients and the impact on outcomes. The process for producing this report is based on an exhaustive review of the literature to assess the evidence for analytical validity, clinical validity and clinical utility of the tests. Ethical, legal and social implications related to testing are also included in the assessment. The full report is available online. A news release that summarizes the major findings is also available.

Posted by Kristin Oehlke on January 18, 2007 2:24 AM |